Abbott Laboratories (ABT)

Investors love dividend stocks because they provide dependable passive income streams and an excellent opportunity for solid total return.

Broader equities have been volatile this year, but that's par for the course. The fact that the stock market will sometimes go through erratic periods is not a good reason not to invest.

With both MDT & ABT focusing on their core strengths, the stage is set for a compelling comparison. Let's see which stock is poised for greater upside.

Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

If there is one voice on Wall Street that we always listen to, it is Stifel's Barry Bannister, and with good reason.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often ...

Per REFLECT studies, ABT's Libre technology is the first CGM linked to fewer hospitalizations for heart complications in people with diabetes.

Make money without even trying: That's what passive income is all about. But good investment alternatives are required to make this "easy" money.

Abbott (ABT) reported earnings 30 days ago. What's next for the stock?

Drugmaker Abbott India reported a 28% rise in fourth-quarter profit on Thursday, helped by strong demand for its gastrointestinal and anti-infective medications.